Vivo Bio Tech Ltd vs Apollo Hospitals Enterprise Limited

A side-by-side comparison of Vivo Bio Tech Ltd (511509) and Apollo Hospitals Enterprise Limited (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads 511509 vs APOLLOHOSP on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

4.43
P/E ratio
62.56
0.46
P/B ratio
13.46
0.00%
Dividend yield
0.22%
₹4.24
EPS
₹135.04

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

-2.00%
Return on equity
20.48%
9.04%
Return on capital
17.31%
44.05%
EBITDA margin
14.94%
15.60%
Net margin
7.94%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

0.70%
Revenue CAGR (3Y)
14.94%
14.71%
Profit CAGR (3Y)
33.35%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹41 Cr
Market cap
₹1.21L Cr
₹47 Cr
Revenue
₹25,229 Cr
₹7 Cr
Net profit
₹2,003 Cr
0.72
Debt / equity
0.90
Vivo Bio Tech Ltd
  • + ["Stock is trading at 0.45 times its book value"]
  • − ["Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.81%", "The company has delivered a poor sales growth of 0.59% over past five years.", "Promoter holding is low: 30.6%", "Company has a low return on equity of 2.24% over last 3 years."]
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 12.74 times its book value"]
Vivo Bio Tech Ltd full analysis Apollo Hospitals Enterprise Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.